Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 510 du 7 janvier 2022
Qualité de vie, soins de support (4)
Menée en Corée par questionnaire auprès de 136 patients ayant survécu à un cancer de l'estomac, cette étude identifie les facteurs associés à leur qualité de vie
Factors affecting the quality of life of gastric cancer survivors
Menée en Corée par questionnaire auprès de 136 patients ayant survécu à un cancer de l'estomac, cette étude identifie les facteurs associés à leur qualité de vie
Factors affecting the quality of life of gastric cancer survivors
Choi, Jahyun ; Kim, Sanghee ; Choi, Mona ; Hyung, Woo Jin
Background : The number of gastric cancer survivors has been increasing, and such survivors experience various changes in their lives post-recovery. Adapting to these changes requires appropriate interventions that can improve their quality of life (QoL). This study was conducted to investigate the factors affecting the QoL of gastric cancer survivors and provide basic data for effective intervention. Methods : Data were collected between September 8 and September 29, 2017, from the Gastric [...]
Menée aux Pays-Bas par questionnaire auprès de 151 jeunes adultes ayant survécu à un cancer pédiatrique, cette étude analyse les facteurs associés à leurs besoins en soins de support
Support needs of Dutch young adult childhood cancer survivors
Menée aux Pays-Bas par questionnaire auprès de 151 jeunes adultes ayant survécu à un cancer pédiatrique, cette étude analyse les facteurs associés à leurs besoins en soins de support
Support needs of Dutch young adult childhood cancer survivors
van Erp, L. M. E. ; Maurice-Stam, H. ; Kremer, L. C. M. ; Tissing, W. J. E. ; van der Pal, H. J. H. ; Beek, L. ; de Vries, A. C. H. ; van den Heuvel-Eibrink, M. M. ; Versluys, B. A. B. ; van der Heiden-van der Loo, M. ; van Gorp, M. ; Huizinga, G. A. ; Grootenhuis, M. A.
Background : Studies about support needs of young adult childhood cancer survivors (YACCS) previously focused mainly on information needs. This study assessed support needs and associated factors (sociodemographic, medical, and psychosocial functioning) in Dutch YACCS. Methods : YACCS (aged 18–30, diagnosed ≤ 18 years, time since diagnosis ≥ 5 years) cross-sectionally filled out a questionnaire regarding their need for various types of support (concrete information, personal counseling, and [...]
Menée à Taïwan auprès de 123 patients atteints d'un cancer, cette étude transversale analyse l'association entre l'intensité de leur douleur, une prescription médicale d'opioïdes et leur satisfaction vis-à-vis de la prise en charge de la douleur
Relationship between prescribed opioids, pain management satisfaction, and pain intensity in oncology outpatients
Menée à Taïwan auprès de 123 patients atteints d'un cancer, cette étude transversale analyse l'association entre l'intensité de leur douleur, une prescription médicale d'opioïdes et leur satisfaction vis-à-vis de la prise en charge de la douleur
Relationship between prescribed opioids, pain management satisfaction, and pain intensity in oncology outpatients
Wang, Jia-Hua ; Wang, Ling-Wei ; Liang, Shu-Yuan ; Rosenberg, John ; Wang, Tsae-Jyy ; Wu, Shu-Fang ; Liu, Chieh-Yu
Background : Pain is the most severe and commonest symptom for patients with cancer. Patients’ pain management satisfaction is an essential indicator of quality care and further affects their willingness to seek care. Purpose : This study aimed to examine the correlations between patients’ prescribed opioids, pain management satisfaction, and pain intensity. Methods : This study adopted a cross-sectional correlation design, recruited a total of 123 patients with cancer pain through convenience [...]
Mené sur 105 patients atteints d'un cancer de la prostate et 87 partenaires de vie, cet essai randomisé évalue l'intérêt d'une intervention dispensée en ligne pour améliorer leur sexualité après les traitements anticancéreux
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results
Mené sur 105 patients atteints d'un cancer de la prostate et 87 partenaires de vie, cet essai randomisé évalue l'intérêt d'une intervention dispensée en ligne pour améliorer leur sexualité après les traitements anticancéreux
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results
Wittmann, Daniela ; Mehta, Akanksha ; Bober, Sharon L. ; Zhu, Ziwei ; Daignault-Newton, Stephanie ; Dunn, Rodney L. ; Braun, Thomas M. ; Carter, Caroline ; Duby, Ashley ; Northouse, Laurel L. ; Koontz, Bridget F. ; Glodé, L. Michael ; Brandon, Jan ; Bangs, Rick ; McPhail, John ; McPhail, Susan ; Arab, Lenore ; Paich, Kellie ; Skolarus, Ted A. ; An, Lawrence C. ; Nelson, Christian J. ; Saigal, Christopher S. ; Chen, Ronald C. ; Mulhall, John P. ; Hawley, Sarah T. ; Hearn, Jason W. D. ; Spratt, Daniel E. ; Pollack, Craig E.
BACKGROUND : Despite significant sexual dysfunction and distress after localized prostate cancer treatment, patients typically receive only physiologic erectile dysfunction management. The authors performed a randomized controlled trial of an online intervention supporting couples' posttreatment recovery of sexual intimacy. METHODS : Patients treated with surgery, radiation, or combined radiation and androgen deprivation therapy who had partners were recruited and randomized to an online [...]
Observation (4)
Menée en Italie à partir de données 2002-2019 portant sur 6 882 patients atteints d'un carcinome hépatocellulaire, cette étude multicentrique analyse la prévalence d'une stéatose hépatique associée à un dysfonctionnement métabolique ainsi que le risque de décès par cancer
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Menée en Italie à partir de données 2002-2019 portant sur 6 882 patients atteints d'un carcinome hépatocellulaire, cette étude multicentrique analyse la prévalence d'une stéatose hépatique associée à un dysfonctionnement métabolique ainsi que le risque de décès par cancer
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Vitale, Alessandro ; Svegliati-Baroni, Gianluca ; Ortolani, Alessio ; Cucco, Monica ; Dalla Riva, Giulio V ; Giannini, Edoardo G ; Piscaglia, Fabio ; Rapaccini, Gianludovico ; Di Marco, Mariella ; Caturelli, Eugenio ; Zoli, Marco ; Sacco, Rodolfo ; Cabibbo, Giuseppe ; Marra, Fabio ; Mega, Andrea ; Morisco, Filomena ; Gasbarrini, Antonio ; Foschi, Francesco Giuseppe ; Missale, Gabriele ; Masotto, Alberto ; Nardone, Gerardo ; Raimondo, Giovanni ; Azzaroli, Francesco ; Vidili, Gianpaolo ; Oliveri, Filippo ; Pelizzaro, Filippo ; Ramirez Morales, Rafael ; Cillo, Umberto ; Trevisani, Franco ; Miele, Luca ; Marchesini, Giulio ; Farinati, Fabio
Background : Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new inclusive definition of the whole spectrum of liver diseases associated to metabolic disorders. The main objective of this study was to compare patients with MAFLD and non-MAFLD with hepatocellular carcinoma (HCC) included in a nationally representative cohort. Methods : We analysed 6882 consecutive patients with HCC enrolled from 2002 to 2019 by 23 Italian Liver Cancer centres to compare epidemiological [...]
Menée pour 204 pays et territoires sur la période 2010-2019, cette étude présente une estimation de l'incidence des cancers, de la mortalité associée, des années vécues avec de l'incapacité, des années de vie perdues et des années de vie perdues ajustées sur l'incapacité
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to...
Menée pour 204 pays et territoires sur la période 2010-2019, cette étude présente une estimation de l'incidence des cancers, de la mortalité associée, des années vécues avec de l'incapacité, des années de vie perdues et des années de vie perdues ajustées sur l'incapacité
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019
Global Burden of Disease Cancer Collaboration
Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. Objective To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. Evidence Review The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived [...]
Menée aux Etats-Unis, cette étude analyse les disparités ethniques, socioéconomiques et géographiques dans la survie des patients atteints d'un cancer colorectal
Ethnicity, socioeconomic status, income inequality, and colorectal cancer outcomes: evidence from the 4C2 collaboration
Menée aux Etats-Unis, cette étude analyse les disparités ethniques, socioéconomiques et géographiques dans la survie des patients atteints d'un cancer colorectal
Ethnicity, socioeconomic status, income inequality, and colorectal cancer outcomes: evidence from the 4C2 collaboration
Bradley, Cathy J. ; Anderson-Mellies, Amy ; Borrayo, Evelinn A. ; Doherty, Jennifer Anne ; Escontrías, Omar A. ; Garcia, David O. ; Mishra, Shiraz I. ; Sussman, Andrew L. ; Thomson, Cynthia A. ; Wetter, David W. ; Cook, Linda S.
Purpose : National Cancer Institute (NCI)-Designated Cancer Centers are required to assess and address the needs of their catchments. In rural regions, catchment areas are vast, populations small, and infrastructure for data capture limited, making analyses of cancer patterns challenging. Methods : The four NCI-Designated Comprehensive Cancer Centers in the southern Rocky Mountain region formed the Four Corners Collaboration (4C2) to address these challenges. Colorectal cancer (CRC) was [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
Amatu, Alessio ; Pani, Arianna ; Patelli, Giorgio ; Gagliardi, Oscar Matteo ; Loparco, Marina ; Piscazzi, Daniele ; Cassingena, Andrea ; Tosi, Federica ; Ghezzi, Silvia ; Campisi, Daniela ; Grifantini, Renata ; Abrignani, Sergio ; Siena, Salvatore ; Scaglione, Francesco ; Sartore-Bianchi, Andrea
Background: Patients with solid tumours have high COVID-19 mortality. Limited and heterogeneous data are available regarding the immunogenicity of SARS-CoV-2 mRNA vaccines in this population. Methods and Findings: This is a prospective, single-center, cohort study aiming at evaluating seroconversion in terms of anti-spike antibodies in a population of patients with solid tumours undergoing cancer therapy within 2 months before the second vaccine dose, as compared with a cohort of controls. [...]
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy
Ambroggi, Massimo ; Citterio, Chiara ; Vecchia, Stefano ; Riva, Alessandra ; Mordenti, Patrizia ; Cavanna, Luigi
Purpose : Little is known about the real impact of the COVID-19 outbreak on the qualitative and quantitative fall-out on the management of cancer patients. Our objective was to provide evidence of the effects of SARS-COV-2 on the management of cancer patients in the real world. Methods : In a general hospital in a district in Italy with high prevalence of COVID-19 during the first wave, we retrospectively analyzed the data of oncologic activity, namely new cancer diagnosis, types of treatment [...]
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position paper
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position paper
Barrière, J. ; Carles, M. ; Audigier-Valette, C. ; Ré, D. ; Zoubir, A. ; Seitz-Polski, B. ; Gounant, V. ; Descamps, D. ; Zalcman, G.
Taking into account higher risk of severe coronavirus disease 2019 (COVID-19) or death among patients with cancer, as well as impaired immunogenicity following anti-SARS-CoV-2 vaccines, in addition to waning immunity, booster dosing appears mandatory in this patient population. This review sought to provide reasonable evidence so as to assist oncologists in their daily practice, helping them decide when an anti-SARS-Cov2 antibodies (Abs) dosage should be scheduled following a full two-dose [...]
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer patients
Debie, Y. ; Vandamme, T. ; Goossens, M. E. ; van Dam, P. A. ; Peeters, M.
Dear Editor, ancer patients are at increased risk for severe COVID-19 and have reduced humoral immune responses after SARS-CoV-2 infection and dual-dose BNT162b2 vaccination. Recently it was observed that a third dose of BNT162b2 is able to elicit higher SARS-CoV-2 anti-receptor-binding domain (RBD) IgG titers in solid-organ transplant patients and adults aged ≥60 years compared to two doses. Initial reports with limited sample size, also indicated that the a third BNT162b2 vaccination dose [...]
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
Hawley, Jessica E. ; Sun, Tianyi ; Chism, David D. ; Duma, Narjust ; Fu, Julie C. ; Gatson, Na Tosha N. ; Mishra, Sanjay ; Nguyen, Ryan H. ; Reid, Sonya A. ; Serrano, Oscar K. ; Singh, Sunny R. K. ; Venepalli, Neeta K. ; Bakouny, Ziad ; Bashir, Babar ; Bilen, Mehmet A. ; Caimi, Paolo F. ; Choueiri, Toni K. ; Dawsey, Scott J. ; Fecher, Leslie A. ; Flora, Daniel B. ; Friese, Christopher R. ; Glover, Michael J. ; Gonzalez, Cyndi J. ; Goyal, Sharad ; Halfdanarson, Thorvardur R. ; Hershman, Dawn L. ; Khan, Hina ; Labaki, Chris ; Lewis, Mark A. ; McKay, Rana R. ; Messing, Ian ; Pennell, Nathan A. ; Puc, Matthew ; Ravindranathan, Deepak ; Rhodes, Terence D. ; Rivera, Andrea V. ; Roller, John ; Schwartz, Gary K. ; Shah, Sumit A. ; Shaya, Justin A. ; Streckfuss, Mitrianna ; Thompson, Michael A. ; Wulff-Burchfield, Elizabeth M. ; Xie, Zhuoer ; Yu, Peter Paul ; Warner, Jeremy L. ; Shah, Dimpy P. ; French, Benjamin ; Hwang, Clara ; COVID-19 ; Cancer Consortium
Importance : The COVID-19 pandemic has had a distinct spatiotemporal pattern in the United States. Patients with cancer are at higher risk of severe complications from COVID-19, but it is not well known whether COVID-19 outcomes in this patient population were associated with geography. Objective : To quantify spatiotemporal variation in COVID-19 outcomes among patients with cancer. Design, Setting, and Participants : This registry-based retrospective cohort study included patients with a [...]
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
Hayashi, Takuma ; Konishi, Ikuo
The mammalian target of the rapamycin (mTOR) pathway has been demonstrated to be modulated by numerous RNA viruses. Recent evidence points toward modulation of mTOR in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Patients with cancer, who receive antineoplastic agents that suppress the mTOR/phosphoinositide 3-kinase (PI3K) signaling pathway, may have lower SARS-CoV-2 infection rates and coronavirus disease 2019 (COVID-19) severity. COVID-19 pandemic urgently warranted [...]
Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer
Lam, Diana L. ; Flanagan, Meghan R.
A39-year-old healthy woman without family history of malignancy found a mass in her right breast at 38 weeks of pregnancy. Prior to delivery, she underwent diagnostic ultrasound of the right breast, which showed a possible mass in the location of the palpable lesion that was most consistent with a normal island of fibroglandular tissue. Follow-up mammogram and ultrasound of the right breast (without axillary evaluation) were performed 6 months later, which showed an irregular 17-mm mass with [...]
Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey
Neamtiu, Luciana ; Martos, Carmen ; Giusti, Francesco ; Negrao Carvalho, Raquel ; Randi, Giorgia ; Dimitrova, Nadya ; Flego, Manuela ; Dyba, Tadeusz ; Bettio, Manola ; Gavin, Anna ; Visser, Otto ; the ENCR Steering Committee
The COVID-19 pandemic posed a number of challenges to the oncology community, particularly the diagnosis and care of cancer patients while ensuring safety from the virus for both patients and professionals: minimisation of visits to the hospital, cancellation of the screening programmes and the difficulties in the management and operation of cancer registries (CRs) while working remotely.This paper describes the effects in the medium term of the first wave of the COVID-19 pandemic on cancer [...]
COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer
Schmidt, A. L. ; Labaki, C. ; Hsu, C. Y. ; Bakouny, Z. ; Balanchivadze, N. ; Berg, S. A. ; Blau, S. ; Daher, A. ; El Zarif, T. ; Friese, C. R. ; Griffiths, E. A. ; Hawley, J. E. ; Hayes-Lattin, B. ; Karivedu, V. ; Latif, T. ; Mavromatis, B. H. ; McKay, R. R. ; Nagaraj, G. ; Nguyen, R. H. ; Panagiotou, O. A. ; Portuguese, A. J. ; Puc, M. ; Dutra, M. Santos ; Schroeder, B. A. ; Thakkar, A. ; Wulff-Burchfield, E. M. ; Mishra, S. ; Farmakiotis, D. ; Shyr, Yu ; Warner, J. L. ; Choueiri, T. K.
Background : Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of anti-neoplastic systemic therapies can result in less robust antibody titres following vaccination and possible risk of breakthrough infection. As clinical trials evaluating COVID-19 vaccines largely excluded patients with a history of cancer and those on active immunosuppression (including [...]
Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain)
Vives, Nuria ; Binefa, Gemma ; Vidal, Carmen ; Milà, Núria ; Muñoz, Rafael ; Guardiola, Virtudes ; Rial, Olga ; Garcia, Montse
The COVID-19 pandemic caused the suspension at all levels of the Catalan FIT-based CRC screening program on March 12, 2020. Screening invitations to FIT were resumed on September 1, 2020. We aimed to assess the short-term impact of the pandemic and describe strategies implemented to minimize harm by the disruption of the FIT-based CRC screening in the Metropolitan Area of Barcelona. We analyzed participation rate, colonoscopy adherence, time intervals to colonoscopy, detection rates, and [...]
Gender differences in adherence to COVID-19 preventative measures and preferred sources of COVID-19 information among adolescents and young adults...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Gender differences in adherence to COVID-19 preventative measures and preferred sources of COVID-19 information among adolescents and young adults with cancer
Yan, Adam ; Howden, Kaitlyn ; Mahar, Alyson L. ; Glidden, Camille ; Garland, Sheila N. ; Oberoi, Sapna
Background: The COVID-19 pandemic has greatly altered the behavior of adolescents and young adults with cancer. No data exists as to the impact of gender on adherence of individuals with cancer to COVID-19 related public health guidelines and their preferred methods of receiving COVID-19 related information. Methods: We conducted a cross-sectional survey of adolescents and young adults with cancer. Data were summarized using descriptive statistics. Multiple logistic regression was used to [...]
Analyses économiques et systèmes de soins (1)
Menée aux Etats-Unis à partir de questionnaires auprès de 380 patients atteints d'un cancer colorectal métastatique (âge médian : 59,9 ans), cette étude estime l'incidence cumulée des difficultés financières majeures et identifie les facteurs associés
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
Menée aux Etats-Unis à partir de questionnaires auprès de 380 patients atteints d'un cancer colorectal métastatique (âge médian : 59,9 ans), cette étude estime l'incidence cumulée des difficultés financières majeures et identifie les facteurs associés
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
Shankaran, Veena ; Unger, Joseph M. ; Darke, Amy K. ; Suga, Jennifer Marie ; Wade, James L., III ; Kourlas, Peter J. ; Chandana, Sreenivasa R. ; O’Rourke, Mark A. ; Satti, Suma ; Liggett, Diane ; Hershman, Dawn L. ; Ramsey, Scott D.
Background : Financial toxicity is a growing problem in oncology, but no prior studies have prospectively measured the financial impact of cancer treatment in a diverse national cohort of newly diagnosed cancer patients. S1417CD was the first cooperative group-led multicenter prospective cohort study to evaluate financial hardship in metastatic colorectal cancer (mCRC) patients. Methods : Patients aged 18 years or older within 120 days of mCRC diagnosis completed quarterly questionnaires for 12 [...]
Treating the Whole Patient With Cancer: The Critical Importance of Understanding and Addressing the Trajectory of Medical Financial Hardship
Menée aux Etats-Unis à partir de questionnaires auprès de 380 patients atteints d'un cancer colorectal métastatique (âge médian : 59,9 ans), cette étude estime l'incidence cumulée des difficultés financières majeures et identifie les facteurs associés
Treating the Whole Patient With Cancer: The Critical Importance of Understanding and Addressing the Trajectory of Medical Financial Hardship
Yabroff, K. Robin ; Shih, Ya-Chen Tina ; Bradley, Cathy J.
The costs of cancer treatment have grown dramatically over the past decades (1-4). Among patients with health insurance coverage, cost-sharing, including deductibles, copayments, and coinsurance, has also increased, which resulted in increases in out-of-pocket burden that outpaced general inflation (1,4). As a result, patients and their families may need to make trade-offs between paying for their cancer care and basic household needs, such as food, housing, and utilities. Patients may also [...]